Melissa B. Epperly, Chief Financial Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 5,966 shares at $53.99 ($322K) on 2021-06-01, disclosed to the SEC on 2021-06-02.
Open-market sale of $322k ZNTL by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.99 | 2,883 | $156K | 48.3% |
| 2 | $53.99 | 2,883 | $156K | 48.3% |
| 3 | $54.90 | 200 | $11K | 3.4% |
| Total | $54.02 avg | 5,966 | $322K | 100% |
| Filing → |
| ROIV | SELL | 2026-07-01 | $610K | — | Filing → |
| ROIV | SELL | 2026-03-18 | $1.2M | — | Filing → |
| ZNTL | SELL | 2024-02-12 | $29K | — | Filing → |